Are you interested in advancing treatments in Parkinson’s disease? Did you know that the non-motor symptoms of Parkinson’s disease are often very disabling and can lead to poor outcomes with the disease? If you have Parkinson’s disease, you may be eligible to take part in a research study to learn if we can use non-invasive … Read more

This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of CBD administered as ZYN002, a transdermal gel, for the treatment of children and adolescent patients with FXS. Status: Not currently enrolling

With the support of Neurology Clinical Research Pilot Award, the clinical resting state functional MRI service will launch a new clinical trial aiming to transform the treatment of brain injury patients with unnoticed seizures. Seizures are often hard to notice in comatose patients, resulting in prolonged recovery periods and suboptimal outcomes. This trial utilizes resting … Read more

A study is being conducted to understand the effectiveness of ALXN2050 compared with placebo in the treatment of generalized MG (gMG) based on improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) total score. Status: Open

This is a genetic registry study aimed at developing a central location to store Parkinson’s Disease genetic data for future research use. Status: Open

With our sincerest gratitude, the Department of Neurology extends our warmest congratulations to Dr. Nina Browner on reaching 15 years of employment with UNC Chapel Hill! Dr. Browner, along with 385 other employees of UNC-Chapel Hill who have reached the same milestone this year, deserve the well earned recognition for unwavering service and outstanding work. … Read more

Neurology quarterly newsletter for 2023. Look out for our next one in July 2023!   Faculty: Muge Gucsavas Calikoglu, MD, MPH Dr. Muge Gucsavas Calikoglu, who holds positions as Associate Professor in the Department of Pediatrics and Assistant Director of the Medical Genetics Residency Program, has been named an adjunct professor of the Division of … Read more

The UNC Office of Technology Commercialization (OTC) works in partnership with investigators to effectively manage the identification, evaluation, protection, translation and commercialization of impactful inventions and technologies. On April 25, 2023, OTC awarded Dr. Todd Cohen’s lab a Technology Commercialization Grant. Cohen explains, “We will be using this support from the Office of Technology Commercialization … Read more

Circadian rhythm is well known to affect various aspects of sports performance; however, the sport-specific effects in rock climbing are not well studied. We aim to evaluate diurnal changes in maximum finger strength, finger endurance, and power in rock climbers. Status: Not currently enrolling

This study aims to test the safety and effectiveness of batoclimab in treating patients with Myasthenia Gravis. Status: Open